Banner
    Telemedicine Catches Retinopathy Of Prematurity Blinding Disease In Premature Babies
    By News Staff | June 27th 2014 01:01 PM | Print | E-mail | Track Comments

    About 450,000 (12 percent) of the 3.9 million babies born each year in the United States are premature. Thanks to modern medicine, the number of preterm infants who survive has also surged in middle income countries in Latin America, Asia, and Eastern Europe. 

    In these parts of the world, rates of childhood blindness from retinopathy of prematurity (ROP) are estimated at 15 to 30 percent—compared to 13 percent in the United States. Some degree of  retinopathy of prematurity appears in more than half of all infants born at 30 weeks pregnancy or younger—a full-term pregnancy is 40 weeks—but only about 5 to 8 percent of cases become severe enough to require treatment.

    In ROP, blood vessels in the tissue in the back of the eye called the retina begin to grow abnormally, which can lead to scarring and detachment of the retina. Treatment involves destroying the abnormal blood vessels with lasers or freezing them using a technique called cryoablation. Early diagnosis and prompt treatment is the best prevention for vision loss from ROP, which is why the American Academy of Ophthalmology recommends routine screening for all babies who are born at gestational age 30 weeks or younger or who weigh less than 3.3 pounds at birth. 



    All babies born before 31 weeks of pregnancy need monitoring for retinopathy of prematurity. Credit: National Eye Institute


    A recent study evaluated telemedicine for ROP screening during the usual care of 1,257 premature infants who were born, on average, 13 weeks early. About every nine days, each infant underwent screening by an ophthalmologist, who assessed whether referral for treatment was warranted. Those who were referred were designated as having referral-warranted ROP (RW-ROP). Either immediately before or after the exam, a non-physician staff member in the neonatal intensive care unit (NICU) took images of the infant's retinas and uploaded them to a secure server at the University of Oklahoma, Oklahoma City.

    Trained non-physician image readers at the University of Pennsylvania, Philadelphia, then downloaded the photos, independently evaluated them following a standard protocol, and reported the presence or absence of RW-ROP. 

    Through the telemedicine approach, non-physician image readers correctly identified 90 percent of the infants deemed to have RW-ROP based on examination by an ophthalmologist. And they were correct 87 percent of the time when presented with images from infants who lacked RW-ROP. The examining ophthalmologists documented 244 infants with RW-ROP on exam. After referral, 162 infants were treated. Of these, non-physician image readers identified RW-ROP in all but three infants (98 percent).

    "This is the first large clinical investigation of telemedicine to test the ability of non-physicians to recognize ROP at high risk of causing vision loss," said Eleanor Schron, Ph.D., group leader of NEI Clinical Applications. "The results suggest that telemedicine could improve detection and treatment of ROP for millions of at-risk babies worldwide who lack immediate in-person access to an ophthalmologist," she said.

    One advantage of telemedicine ROP screening is that it can be done more frequently than screening by an ophthalmologist. "It's much easier to examine the retina when not dealing with a wiggling baby," said Graham E. Quinn, M.D., professor of ophthalmology at the Children's Hospital of Philadelphia and the lead investigator for the study. "If a baby is too fussy or otherwise unavailable when the ophthalmologist visits the NICU, the exam may be delayed until the ophthalmologist returns—sometimes up to a week later." 

    Weekly ROP screening—or even more frequently for high-risk babies—is a realistic goal for telemedicine and could help catch all cases needing treatment, according to the report. In the study, imaging was restricted to occasions when an ophthalmologist examined the baby. In practice, hospital staff could implement an imaging schedule based on the baby's weight, age at birth, and other risk factors. "With telemedicine, NICU staff can take photos at the convenience of the baby," said Quinn.

    Telemedicine for evaluating ROP offers several other advantages. Telemedicine may help detect RW-ROP earlier. In the study, about 43 percent of advanced ROP cases were identified by telemedicine before they were detected by an ophthalmologist—on average, about 15 days earlier. Telemedicine could save babies and their families the hardship and hazards of being unnecessarily transferred to larger nurseries with greater resources and more on-site ophthalmologists.

    "Telemedicine potentially gives every hospital access to excellent ROP screening," Quinn said. 

    Telemedicine might also bring down the costs of routine ROP screening by reducing the demands on ophthalmologists, whose time is better allocated to babies who need their attention and expertise. In a separate analysis, the study found that non-physicians and physicians had similar success in assessing photos for RW-ROP. Three physicians evaluated image sets from a random sample of 200 babies (100 with RW-ROP based on the eye exam findings; 100 without) using the standard grading protocol.

    On average, the physicians correctly identified about 86 percent of RW-ROP cases; the non-physicians were correct 91 percent of the time. The physicians correctly identified about 57 percent of babies without RW-ROP; non-physicians were correct 73 percent of the time.

    The cost of establishing a telemedicine ROP screening program includes acquisition of a special camera for taking pictures of the retina, training of NICU personnel to take and transmit quality photos, and establishment and maintenance of an image reading center. "As we move along this road, advances in imaging and grading of images may streamline the process even more," Dr. Quinn said.


    Published in JAMA Ophthalmology. Source: NIH/National Eye Institute